|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 6 June 2007
doi: 10.1242/dev.003707
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meeting Review |
1 Vascular Biology Program, Departments of Pathology and Surgery, Children's
Hospital and Harvard Medical School, Boston, MA 02115, USA.
2 Center for Regenerative and Developmental Biology, Forsyth Institute, and
Developmental Biology Department, Harvard School of Dental Medicine, Boston,
MA 02115, USA.
* Author for correspondence (e-mail: donald.ingber{at}childrens.harvard.edu)
SUMMARY
At a recent Keystone Symposium on `Developmental Biology and Tissue Engineering', new findings in areas ranging from stem cell differentiation, embryonic pattern formation and organ regeneration to engineered cell microenvironments, synthetic biomaterials and artificial tissue fabrication were described. Although these new advances were exciting, this symposium clarified that biologists and engineers often view the challenge of tissue formation from different, and sometimes conflicting, perspectives. These dichotomies raise questions regarding the definition of regenerative medicine, but offer the promise of exciting new interdisciplinary approaches to tissue and organ regeneration, if effective alliances can be established.
This article has been cited by other articles:
![]() |
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop Stem Cells and Cell Therapies in Lung Biology and Lung Diseases Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667. [Full Text] [PDF] |
||||